Document is current
Any future updates will be listed below
-
Authors
Erfurth, Andreas
- License Information
-
More Information
Article History
Accepted: 18 September 2023
First Online: 16 October 2023
Interessenkonflikt
: A. Erfurth: Vorträge und/oder Advisory Boards für Angelini, Boehringer Ingelheim, Germania, Janssen, Lundbeck, Mylan, Neuraxpharm, Recordati und Sandoz.
Free to read: This content has been made available to all.
